SmallCap Trading Techniques

[I Like Bottom Fishing]

MCET CHART 0.0046

http://www.multicelltech.com/

http://www.otcmarkets.com/stock/MCET/company-info

http://www.otcmarkets.com/stock/MCET/news

http://www.knobias.com/individual/public/quote.htm?ticker=MCET

http://www.otcmarkets.com/stock/MCET/financials

http://www.otcmarkets.com/stock/MCET/short-sales

https://delecorp.delaware.gov/tin/GINameSearch.jsp

MultiCell Technologies, Inc. CIK#: 0000811779 (see all company filings)
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000811779&owner=exclude&count=40

MultiCell Technologies, Inc. (0000811779)
http://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0000811779

http://www.sec.gov/cgi-bin/browse-edgar?company=MultiCell+Technologies&match=&CIK=0000811779&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

http://www.insidestocks.com/texadv.asp?sym=MCET

http://www.insidestocks.com/quote.asp?sym=MCET

http://www.barchart.com/quotes/stocks/MCET






























*MCET CHART WEEKLY*















[chart]stockcharts.com/c-sc/sc?s=MCET&p=W&yr=1&mn=6&dy=23&i=p50204424895&r=7872[/ch art]

MCET News MultiCell Technologies Receives Stem Cell Patent

Friday, June 3, 2011 4:18 AM

Scottrade.com
This email is compliments of Scottrade.com

http://www.multicelltech.com/

http://www.otcmarkets.com/stock/MCET/company-info

http://www.otcmarkets.com/stock/MCET/news

http://www.knobias.com/individual/public/quote.htm?ticker=MCET

http://www.otcmarkets.com/stock/MCET/financials

http://www.otcmarkets.com/stock/MCET/short-sales

https://delecorp.delaware.gov/tin/GINameSearch.jsp

MultiCell Technologies, Inc. CIK#: 0000811779 (see all company filings)
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000811779&owner=exclude&count=40

MultiCell Technologies, Inc. (0000811779)
http://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0000811779

http://www.sec.gov/cgi-bin/browse-edgar?company=MultiCell+Technologies&match=&CIK=0000811779&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

http://www.insidestocks.com/texadv.asp?sym=MCET

http://www.insidestocks.com/quote.asp?sym=MCET

http://www.barchart.com/quotes/stocks/MCET

News for 'MCET' - (MultiCell Technologies Receives Stem Cell Patent)

Jun 03, 2011 (Close-Up Media via COMTEX) -- MultiCell Technologies, Inc.
announced the issuance of U.S. patent 7,935,528 by the United States Patent and
Trademark Office (USPTO) relating to the isolation and use of human liver stem
cells to treat liver disease.

The Company said under the terms of its license agreement with Rhode Island
Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S.
patent 7,935,528.

The patent describes methods to isolate and use human liver stem cells to treat
degenerative liver diseases, or inherited deficiencies of liver function.
Patients who suffer from severe, irreversible liver disease for which other
medical and surgical treatments have failed are often candidates for a liver
transplant. Liver stem cells which differentiate into functional mature
hepatocytes could help to reconstitute a diseased liver, and may be an
alternative approach to whole organ transplants for certain liver diseases.

"We are pleased the USPTO has agreed that our liver stem cells are indeed novel
and may lead to important therapeutic applications," said W. Gerald Newmin,
Chairman and Chief Executive Officer. "Our efforts to better understand liver
stem cell biology, and the role these cells play in chronic liver disease and
primary hepatocellular carcinoma, is a major focus of the Company," Newmin
stated.

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company
developing novel therapeutics and discovery tools that address unmet medical
needs for the treatment of neurological disorders, hepatic disease and cancer.

More information:

multicelltech.com

((Comments on this story may be sent to [e-mail]))

Copyright Close-Up Media, Inc. 2011. All Rights reserved

-0-

http://www.multicelltech.com/

http://www.otcmarkets.com/stock/MCET/company-info

http://www.otcmarkets.com/stock/MCET/news

http://www.knobias.com/individual/public/quote.htm?ticker=MCET

http://www.otcmarkets.com/stock/MCET/financials

http://www.otcmarkets.com/stock/MCET/short-sales

https://delecorp.delaware.gov/tin/GINameSearch.jsp

MultiCell Technologies, Inc. CIK#: 0000811779 (see all company filings)
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000811779&owner=exclude&count=40

MultiCell Technologies, Inc. (0000811779)
http://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0000811779

http://www.sec.gov/cgi-bin/browse-edgar?company=MultiCell+Technologies&match=&CIK=0000811779&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

http://www.insidestocks.com/texadv.asp?sym=MCET

http://www.insidestocks.com/quote.asp?sym=MCET

http://www.barchart.com/quotes/stocks/MCET

INDUSTRY KEYWORD: Health_And_Beauty_Close-up

Source: Comtex Wall Street News

New Demand & Necessity Buoy Industry -- Insight on MultiCell Technologies, Inc. and Aradigm Corporation.

Thursday , June 02, 2011 09:00ET

http://www.knobias.com/story.htm?eid=3.1.192033a3a248bf2f8eb82e55a8e6f6a2dbefd7f19e680dbff4252d6d3ec63d96

http://www.multicelltech.com/

http://www.otcmarkets.com/stock/MCET/company-info

http://www.otcmarkets.com/stock/MCET/news

http://www.knobias.com/individual/public/quote.htm?ticker=MCET

http://www.otcmarkets.com/stock/MCET/financials

http://www.otcmarkets.com/stock/MCET/short-sales

https://delecorp.delaware.gov/tin/GINameSearch.jsp

MultiCell Technologies, Inc. CIK#: 0000811779 (see all company filings)
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000811779&owner=exclude&count=40

MultiCell Technologies, Inc. (0000811779)
http://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0000811779

http://www.sec.gov/cgi-bin/browse-edgar?company=MultiCell+Technologies&match=&CIK=0000811779&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

http://www.insidestocks.com/texadv.asp?sym=MCET

http://www.insidestocks.com/quote.asp?sym=MCET

http://www.barchart.com/quotes/stocks/MCET

BEIJING -- (Marketwire) -- 06/02/11 -- Today, www.GlobalEquityReporter.com announced its research report highlighting MultiCell Technologies, Inc. (OTCBB: MCET) and Aradigm Corporation (OTCBB: ARDM). Full report download is available at http://www.GlobalEquityReporter.com/access.php.

Several new innovators within the healthcare field have buoyed an influx of new interest to the industry. Combining medical technology with human touch, the healthcare industry diagnoses, treats, and administers care around the clock- responding to the needs of millions of people. Occupational projections show concentrated growth within the industry, a result of the growing demand for improved medical care in both developed and developing economies. The global medical industry is one of the world's fastest growing, absorbing over 10% of the Gross Domestic Product of most developed countries.
Global Equity is reporting on MultiCell Technologies, Inc. for its engagement in developing therapeutics and discovery tools to address unmet medical needs for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology and peripheral vessel applications. MultiCell is pursuing research and development targeting degenerative neurological diseases, including multiple sclerosis (MS) and cancer. The full report and profile on MultiCell Technologies, Inc. (OTCBB: MCET) is available here: http://www.GlobalEquityReporter.com/get.PDF.1824.php.

Global Equity Reporter brings Aradigm Corporation to light as a breath of fresh air, as a specialty pharmaceutical company focused on advanced inhalation delivery. The company's emphasis is directly on the antibiotic ciprofloxacin, which is currently FDA approved. Aradigm has discovered that delivery by inhalation can effectively treat infections associated with severe respiratory diseases such as: cystic fibrosis and bronchiectasis. The full report and profile on Aradigm Corporation (OTCBB: ARDM) is available here: http://www.GlobalEquityReporter.com/get.PDF.1937.php.

About Global Equity Reporter
Global Equity Reporter is a premier source for microcap research - providing a wide range of due diligence and investment insight on stocks all over the market Global Equity Reporter's primary focus is to alert our valued subscribers to small cap and microcap companies poised for explosive movement in the market. As every investor knows, timing in the market is critical, and that's where Global Equity Reporter delivers. We report potential market opportunity to our members before the same situation grows to become strong market momentum, enabling our members to see strong market growth by delivering information before the crowd.

Contact:

Alexander Griffin
Email Contact
http://www.GlobalEquityReporter.com

Source: Global Equity Reporter

Public Companies Associated with this story:
ARDM MCET

Content provided by Market Wire Copyright © 2011
Content transmitted by Knobias.com Copyright © 2011 Visit Knobias.com

http://www.knobias.com/story.htm?eid=3.1.192033a3a248bf2f8eb82e55a8e6f6a2dbefd7f19e680dbff4252d6d3ec63d96

http://www.multicelltech.com/

http://www.otcmarkets.com/stock/MCET/company-info

http://www.otcmarkets.com/stock/MCET/news

http://www.knobias.com/individual/public/quote.htm?ticker=MCET

http://www.otcmarkets.com/stock/MCET/financials

http://www.otcmarkets.com/stock/MCET/short-sales

https://delecorp.delaware.gov/tin/GINameSearch.jsp

MultiCell Technologies, Inc. CIK#: 0000811779 (see all company filings)
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000811779&owner=exclude&count=40

MultiCell Technologies, Inc. (0000811779)
http://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0000811779

http://www.sec.gov/cgi-bin/browse-edgar?company=MultiCell+Technologies&match=&CIK=0000811779&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

http://www.insidestocks.com/texadv.asp?sym=MCET

http://www.insidestocks.com/quote.asp?sym=MCET

http://www.barchart.com/quotes/stocks/MCET

ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2011 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.